It may be that the less aggressive nature of ERα-positive endometrial carcinomas relates to the up-regulation of the miR-200 family, which, in turn, maintains an epithelial phenotype and resists the EMT transition. The gene discussed is ESR1; the disease is endometrial carcinoma.